🇺🇸 FDA
Patent

US 8389731

Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

granted A61PA61P25/28

Quick answer

US patent 8389731 (Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase) held by Northwestern University expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P25/28